Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Louisiana Industry Journal.

Limited-Time Pricing Announced for Gulfstream Ameri-Lite 177BH Travel Trailer
Limited-time pricing now available on the Gulfstream Ameri-Lite 177BH Travel Trailer—don’t miss this affordable RV deal! ALBANY, LA, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Bent’s RV announces a new limited-time promotional price for...

Axovia Therapeutics Unveils New Preclinical Data for AXV-201, for Treatment of Genetic Obesity Caused by MC4R Mutations, at ASGCT
LONDON, May 15, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and obesity, announced that today it will unveil new preclinical proof-of-concept data for...

Best No Credit Check Loans Guaranteed Approval Same Day Deposit in 2025 - Hoverday’s Direct Lenders
DALLAS, May 13, 2025 (GLOBE NEWSWIRE) -- No credit check loans guaranteed approval services have been expanded by Hoverday as part of its mission to deliver accessible financial solutions for customers with challenging credit backgrounds who...

Joe Bonamassa Hits the Gas With New Single 'Drive By the Exit Sign'
Slide Guitar and Southern Swagger Power the Latest Track from Upcoming Studio Album ‘Breakthrough’ NASHVILLE, TN, UNITED STATES, May 23, 2025 /EINPresswire.com/ -- Guitar slinger and blues-rock powerhouse Joe Bonamassa has released his latest...

El Pollo Loco Introduces New Fresca Salads and Wraps
Portable, craveable items give consumers a whole new reason to say “Let’s Get Loco™” COSTA MESA, Calif., May 15, 2025 (GLOBE NEWSWIRE) -- El Pollo Loco, the nation's leading fire-grilled chicken restaurant, is asking customers: Do you want your...

Stylus Medicine Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting
Stylus Medicine, Inc. (“Stylus”), a biotechnology company dedicated to developing transformative in vivo genetic medicines, today announced presentations showcasing its genome engineering approach and in vivo CAR-T platform at the American Society...

Prometric Announces Sponsorship of PGA TOUR Golfer Ben Griffin
BALTIMORE, May 14, 2025 (GLOBE NEWSWIRE) -- Prometric®, a global leader in credentialing and skills development, proudly announces its sponsorship of PGA TOUR golfer Ben Griffin. Known for his precision and dedication on the golf course, Griffin...

Orchard Therapeutics Announces New England Journal of Medicine Publication of Long-term Clinical Outcomes from its HSC Gene Therapy for MLD and Multiple Presentations at ASGCT 2025
LENMELDY™ is the first and only disease-modifying intravenous infusion proven to extend life expectancy in pre-symptomatic late infantile (PSLI) patients and mitigate the cognitive and/or physical impact of early-onset MLD Six accepted abstracts...

Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting
PRESS RELEASE Preclinical insights into dosing for first-in-human in vivo liver-directed gene therapy for MMA delivered in an oral presentation at the ASGCT Annual Meeting Milan, ITALY – 14 May 2025 – Genespire, a biotechnology company developing...

IES Holdings Appoints Kelly C. Janzen to its Board of Directors
HOUSTON , May 13, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced the appointment of Kelly C. Janzen to its Board of Directors (“Board”), effective May 12, 2025. “We’re excited to welcome...

Top Gun Aviation Partners with LiveATC.net to Bring Real-Time Hammond Tower Feeds to the Public
HAMMOND, LA, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- Top Gun Aviation, the premier Fixed Base Operator (FBO) at Hammond Northshore Regional Airport (KDHC), is proud to announce a new partnership with LiveATC.net, the world’s leading...

Editas Medicine Reports New In Vivo Data Highlighting the Potential of Editas’ Gene Upregulation Strategy in HSCs at the American Society of Gene and Cell Therapy Annual Meeting
Data demonstrate therapeutically relevant editing levels using a clinically validated strategy, supporting its development as a novel, in vivo approach to treating sickle cell disease and beta thalassemia CAMBRIDGE, Mass., May 14, 2025 (GLOBE...

Arbor Biotechnologies to Present Preclinical Data for ABO-101 in PH1 at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
– Data from oral presentation supported ABO-101 IND and CTA approval for clinical assessment in primary hyperoxaluria type 1 (PH1) in the Phase 1/2 redePHine study in US and UK (NCT06839235) – Preclinical data demonstrate highly specific and...

Excision BioTherapeutics Presents Data from HBV and HSV Programs at the ASGCT 2025 Annual Meeting
Poster presentation to demonstrate EBT-107’s potential to reduce clinically-relevant biomarkers and HBV DNA integration toward functional remission of chronic hepatitis B Oral presentation to highlight significant reduction in HSC-1 viral load in...

GenVivo Highlights GEN2 Phase 1 Data and GEN-1013 Preclinical Data at the 2025 American Society of Gene + Cell Therapy (ASGCT) Annual Meeting
GEN2 is well tolerated with minimal toxicity and signs of pharmacodynamic activity in an ongoing Phase 1 dose escalation and expansion trial. GEN-1013 was studied in aggressive murine cancer models using both IV and IT administration; prolonged...

Brown-Forman Announces Significant Evolution in U.S. Distribution
Brown-Forman Corporation (NYSE:BFA,BFB) today announced the successful completion of its Request for Proposal (RFP) process for portfolio distribution in select markets across the United States. The company named new distributors for 13 markets, a...

ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing...

Axovia Therapeutics Presents New Preclinical Data for AXV-101 for the Treatment of Blindness Associated with BBS Mutations at ASGCT
- Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025 LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to address the genetic causes of blindness and...

Encoded Therapeutics Presents Promising New Data for CNS Gene Therapy Programs at the ASGCT 28th Annual Meeting
Encoded Therapeutics Inc., a clinical-stage biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today announced the results of preclinical studies that underscore the strength of the Company’s...

Cellectis Reports Financial Results for the First Quarter 2025
Lasme-cel (UCART22) Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025 Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r NHL) ongoing with readout expected in late...